Jazz Pharmaceuticals gets US FDA approval of Xywav for cataplexy associated with narcolepsy Read more
ACADIA Announces FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZID Read more
XyloCor Therapeutics Doses Patients in Phase 1/2 Trial Evaluating Novel Gene Therapy XC001 in Refractory Angina Read more
Mateon and Asili Research Alliance Enter Into Partnership for the Development of Artemisinin Against Covid-19 Read more